PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Pharm Exec 50 Hints to Rest of '19

New Strategies Sought to Pay for Costly Cures

Impact Investing and R&D

Pharma50
Pharm Exec's Top 50 Companies 2019
Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market.
... /Read more/
Advertisement
Deloitte's 2019 Life Sciences accounting and financial reporting update
Insights on new accounting standards and more
A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment.
Download the full report here
Changing the Balance of Negotiation to Impact Drug Prices
In the second in a series of articles summarizing efforts to put each of the "American Patients First" blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on "Better Negotiation."
... /Read more/
ADVERTISEMENT
Calendar
 
/ Leadership for Drug Development Teams – 7/8–7/9 /
 
/ Direct-to-Patient Clinical Trials – 8/8–8/9 /
 
/ 13th Annual Forum on Transparency & Aggregate Spend – 8/12–8/14 /
 
/ 340B Manufacturer Summit – 8/20–8/21 /
 
/ 4th Annual Partnering with IDNs BioPharma Strategy Summit – 8/21–8/22 /
 
 
The Washington Report
Will Congress Enact Curbs on Drug Pricing?
Congress is weighing in on drug pricing with a range of measures that differ in style and substance.
... /Read more/
Advertisement
The Future of Selling Healthcare: An approach to disruptive change
Pharmaceutical sales leaders can no longer just think about how many reps they need and how to structure their sales forces by product and franchise. Instead, we need to reconsider not only how we evolve the role of the rep, but how we define work, how our teams work together, and how we manage, which will, in aggregate, redefine the future of selling. This e-book provides a detailed analysis that describes how and why organizations must adapt to disruptive changes.
Download eBook
Digital Pharma
Digital Therapeutics Can Break Down Barriers to Innovation to Benefit Patients
Pharma companies are increasingly turning to tech enabled behavioral-based interventions to help improve patient outcomes through their diagnosis, treatment, and coordination of care.
... /Read more/
Translationally Enabled Pharma
The Pharm Exec Podcast: Episode 33
Editors speak with Jigar Raythatha, CEO of Constellation Pharmaceuticals. He talks about his roles, the importance of having a Plan B in biotech, creating a translationally enabled company, and how he leads his team at Constellation.
... /Read more/
ADVERTISEMENT
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com